Browsing: drugs

A new Ohio State University research study with the Ohio Restaurant and Hospitality Alliance shows the popularity of weight loss drugs like GLP-1 is changing the way people eat at restaurants. Nearly a quarter of American households report having at least one person using GLP-1

Glucagon-like peptide-1 (GLP-1) receptor agonists, mainly used to treat type 2 diabetes and obesity, are associated with a significantly higher risk of hair loss than other diabetes medications, according to a new study published inThe BMJ

A study of 50,000 people found a link between GLP-1 agonists and alopecia. Regulators in the US and UK have received hundreds of reports of hair loss

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

People on GLP-1 agonist drugs, such as Mounjaro, Ozempic and Wegovy, have been reporting hair loss to regulators and a new study on around 50,000 people appears to support the link

GLP-1 drugs such as Wegovy and Ozempic have been revolutionary for obesity and type 2 diabetes treatments, but questions remain about some of the side effects and potential negative impacts of these medications

Taking GLP-1 weight loss drugs is helping to reduce sick leave by more than 17 percent, a new paper shows, leading to saved costs for employees and employers alike

The GLP-1 craze may be coming for Fido and Fluffy next. Two U.S. biotech companies are testing weight-loss treatments for overweight cats, opening the door to a potential new era of prescription obesity medicine for animals

1 drugs could lead to cost savings for workers and their employers by reducing employee sick leave, a new economic study finds. 

Global Weight Loss Drugs Market to Reach USD 342.58 Billion Press release Global Weight Loss Drugs Market to Reach USD 342.58 Billion by 2034, Driven by Rising Obesity Rates and Next-Generation Hormonal Therapies 07-22-2026 03:19 PM CET | Advertising, Media Consulting, Marketing ResearchPress release from: The Report Cube Global Weight Loss Drugs Market is poised…